IGC Pharma, Inc. (IGC)
0.3458
+0.05
(+16.04%)
USD |
NYAM |
Dec 10, 14:27
IGC Pharma Total Assets (Quarterly): 9.743M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Esperion Therapeutics, Inc. | 364.02M |
| Theravance Biopharma, Inc. | 415.46M |
| NRX Pharmaceuticals, Inc. | 15.00M |
| CEL-SCI Corp. | 20.34M |
| AIM ImmunoTech, Inc. | 5.494M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.651M |
| Shareholders Equity (Quarterly) | 8.092M |
| Debt to Equity Ratio | 0.0185 |
| Current Ratio | 1.324 |
| Net Debt Paydown Yield | 0.10% |